Medical/Pharmaceuticals

Latest Global Survey from ISAPS Reports Continuing Rise in Aesthetic Surgery Worldwide

Total surgical and nonsurgical procedures increased by 7.4% in 2019 HANOVER, N.H., Dec. 9, 2020 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, showing a 7.4% increase in cosme...

2020-12-09 01:00 2658

TCAI at St. David's Medical Center hosts virtual international symposium on complex cardiac arrhythmias with record turnout

AUSTIN, Texas, Dec. 8, 2020 /PRNewswire/ -- On December 3 and 4, 2020, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fifth international symposium on complex arrhythmias, EPLive 2020. This year's event, which was held virtually due to the ongoing pandemic,...

2020-12-08 23:08 3177

BitePRO Survey Confirms Many Workers Are At Risk Of Being Bitten

WETHERBY, England, Dec. 8, 2020 /PRNewswire/ -- The result of an international web-based survey, conducted by Britishbite resistant clothing manufacturer BitePRO, is highlighting the risk of human bite injuries in the workplace.

2020-12-08 22:21 2664

Sonendo® Reaches 500,000 Patients Treated Milestone with the GentleWave® Procedure

LAGUNA HILLS, Calif., Dec. 8, 2020 /PRNewswire/ -- Sonendo, Inc., a leading dental technology company and developer of theGentleWave® System, today announced that more than 500,000 patients have been treated with the GentleWave Procedure.

2020-12-08 21:32 2127

Henlius Adalimumab Biosimilar Approved by NMPA

SHANGHAI, Dec. 8, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the adalimumab biosimilar HLX03, developed and manufactured by the Company independently, has been approved by the National Medical Products Administration (NMPA) for the treatment of rheumatoid arthrit...

2020-12-08 21:00 2874

Novaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease

- ESSENCE-2 is the second registration trial to complete the clinical development of CyclASol® as agreed with U.S. Food and Drug Administration (FDA) - Designed to replicate efficacy demonstrated in previous phase 2/3 ESSENCE-1 trial - Topline data expected in 2nd half 2021 HEIDELBERG, Germany,...

2020-12-08 21:00 1304

VeeMed Acclaimed by Frost & Sullivan for Enabling Operational Excellence with its Turnkey Telemedicine Solution

LONDON, Dec. 8, 2020 /PRNewswire/ -- Based on its recent analysis of the North American telehealth market, Frost & Sullivan recognizesVeeMed, Inc. with the 2020 North American Entrepreneurial Company of the Year Award. Leveraging intelligent technologies, the company provides an integrated patien...

2020-12-08 19:00 1378

Nuance Pharma Closes Series D Financing

SHANGHAI, Dec. 8, 2020 /PRNewswire/ -- Nuance Pharma, a biopharmaceutical company engaged in creating value throughChina's specialty pharmaceutical markets with an established focus on iron deficiency, pain management and respiratory, today announced that it has successfully closed its Series D ...

2020-12-08 17:34 3152

Now is the Time to Be a Hong Kong Heart Hero; Act and Save a Life

Out-of-hospital sudden cardiac arrest kills about 5,000 Hong Kong people each year, if bystanders know CPR and can access a defibrillator, we could save more lives Having already played a role in 100 documented life-saving rescues, Hong Kong's Pacific Medical Systems Limited wants to deliver an ...

2020-12-08 16:14 1893

Nuance Pharma Closes Series D Financing

SHANGHAI, Dec. 8, 2020 /PRNewswire/ -- Nuance Pharma, a biopharmaceutical company engaged in creating value throughChina's specialty pharmaceutical markets with an established focus on iron deficiency, pain management and respiratory, today announced that it has successfully closed its Series D ...

2020-12-08 16:00 4544

Elekta reports major milestones achieved in MR-guided radiotherapy

STOCKHOLM, Dec. 8, 2020 /PRNewswire/ -- During the European Society for Radiotherapy and Oncology (ESTRO) and American Society for Radiation Oncology (ASTRO) Annual Meetings, users of the Elekta Unity MR-Linac presented 69 abstracts recounting the past years' worth of clinical experience with thi...

2020-12-08 15:30 2821

Syntellix Lauded by Frost & Sullivan for Breakthrough Technology in the Orthopedic and Trauma Market with its Bioresorbable Orthopedic Implant, MAGNEZIX

LONDON, Dec. 8, 2020 /PRNewswire/ -- Based on its recent analysis of the European orthopedic and trauma market, Frost & Sullivan recognizesSyntellix AG with the 2020 European Entrepreneurial Company of the Year Award. Its MAGNEZIX products are the world's first magnesium-based, metallically stabl...

2020-12-08 13:00 1131

Willis Towers Watson's Survey Expects Medical Costs in Indonesia to Increase up to 12% in 2021

JAKARTA, Indonesia, Dec. 8, 2020 /PRNewswire/ -- Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, announced it expects medical costs inIndonesia to increase up to 12%. Willis Towers Watson announced the findings following an in-depth report which cite...

2020-12-08 11:37 6881

Ascentage Pharma Announces Positive Data from Pivotal Phase II Studies of HQP1351 (Olverembatinib) in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) at 2020 American Society of Hematology (ASH) Annual Meeting

SUZHOU, China, and ROCKVILLE, MD, Dec. 8, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today reported positive data from two pivotal...

2020-12-08 08:16 2424

Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2020-12-08 08:00 4719

A­­­­­izon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing

Aizon accelerates pharma manufacturing by bolstering the client's currently deployed technology with AI and ML capabilities to boost production performance SANTA CLARA, Calif., Dec. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the North American artificial intelligence (AI) market for ...

2020-12-08 01:57 1531

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

SAN FRANCISCO, Dec. 7, 2020 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnership with Pfizer Inc. (NYSE: PFE) with the goal of accelerating small molecule drug discovery by developing a ...

2020-12-07 22:37 4005

Chaim Lotan, MD announces the official launch of DiNovA's Israel Incubator at ICI

TEL AVIV, Israel, Dec. 7, 2020 /PRNewswire/ -- December 7th, 2020, Chaim Lotan, MD announced the official launch of DiNovA Israel Incubator at the DiNovA Session of ICI (Innovations in Cardiovascular Interventions) 2020 Global Digital Summit. Earlier this year in April, Hangzhou Dinova Ruihua Me...

2020-12-07 21:50 2291

Global Cord Blood Corporation Announces Results of 2020 Annual General Meeting

HONG KONG, Dec. 7, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2020 Annual Ge...

2020-12-07 21:30 8122

Merck Expands Life Science Production Capacities in the United States

-- Expansions to significantly increase capacity by end of 2021 to meet unprecedented demand -- Combined expansion of Danvers, Massachusetts, and Jaffrey, New Hampshire, USA facilities to create nearly 700 new positions -- Business sector's announced 2020 investments total more than € 350 millio...

2020-12-07 21:00 2462
1 ... 321322323324325326327 ... 397

Week's Top Stories